Thanks to visit codestin.com
Credit goes to link.springer.com

Skip to main content
Log in

Orphanet Journal of Rare Diseases

Publishing model:
Open access

Overview

Encompassing all aspects of rare diseases and orphan drugs, Orphanet Journal of Rare Diseases features high quality reviews and original articles in translational, clinical, and epidemiological research submitted from experts in the field, in addition to results of clinical trials of exceptional interest. The journal is also interested in the topics of public health, quality of life, drug and research policies, and health economics in rare diseases. We utilize section editorial boards featuring subject specialists in the many different types of rare diseases we cover.  As the official journal of Orphanet, the portal for rare diseases and orphan drugs, we serve an essential role in a domain where there are more questions than answers.

Editor-in-Chief
  • Francesc Palau

Societies and partnerships

Journal metrics

Journal Impact Factor
3.5 (2024)
5-year Journal Impact Factor
4.0 (2024)
Submission to first decision (median)
34 days
Downloads
4.6M (2024)

Calls for papers

View all calls for papers

Latest articles

Journal updates

Journal information

Electronic ISSN
1750-1172

© Institut National de la Santé et de la Recherche Médicale (INSERM)

Journal navigation